Clinical Research Directory
Browse clinical research sites, groups, and studies.
Amino Acid Nutrition in the Critically-ill
Sponsor: Arnold Kristof
Summary
Enhancing the anabolic effect of nutrition in critically ill patients by administering exogenous amino acids.
Official title: Enhancing the Anabolic Effect of Nutrition in Critically Ill Patients by Administering Exogenous Amino Acids
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2017-03-01
Completion Date
2026-02-28
Last Updated
2025-10-06
Healthy Volunteers
No
Conditions
Interventions
Peptamen 1.5% via enteral
Study patients in this group will be prescribed 1.0 g/kg/d of protein using standard enteral Peptamen 1.5%. Based on current compliance or tolerance statistics, investigators expect patients to only receive 50-60% of these prescribed doses; effective protein intake will therefore be approximately 0.5-0.6 g/kg/d.
Prosol 20% IV to 1.75g/kg/day
Patients in group 2 will receive Peptamen 1.5% but in addition, will receive sufficient intravenous amino acid supplements (Prosol 20%) to achieve an effective fixed dose of 1.75 g/kg/day.
Prosol 20% IV to 2.5g/kg/day
Patients in this group will receive intravenous amino acids, Prosol 20% in addition to standard enteral Peptamen 1.5% to achieve an effective protein intake of 2.5 g/kg/d.
Locations (1)
McGill University health Centre
Montreal, Quebec, Canada